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Abstract
The JL8 protein antigen from Trypanosoma cruzi, a dominant immunogen in man, has been characterized as containing
tandem amino acid repeats. Here, we describe the use of the LamB protein of Escherichia coli as a carrier of JL8 derived
sequences in order to map the immunodominant B cell epitopes in this antigen. Five different sequences of JL8 were inserted in
the LamB protein and the JL8-LamB fusion proteins were tested by ELISA with human chronic chagasic sera. The fusion
carrying the sequence AEKQKAAEATKVAE was recognized by most sera. This protein was also capable of inhibiting the
binding of human chagasic antibodies to GST-JL8 in competitive ELISA suggesting that it contains an immunodominant B
cell epitope of JL8. z 1998 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Chagas’ disease is a zoonosis caused by the proto-
zoan parasite Trypanosoma cruzi, which a¡ects a
large number of individuals in Central and South
America. Because in many cases the infection be-
comes chronic, with hardly any parasite detectable
in the blood of patients, serological tests are invalu-
able for the diagnosis of this disease [1]. Routinely,
crude preparations of the parasite’s antigens are used
in these assays. Many antigenic proteins have had
their coding sequences cloned and characterized by
serological screening of expression libraries in at-
tempts to obtain better reagents for more sensitive
and speci¢c diagnostic tests [2]. Most of the cloned
antigens contain tandem amino acid repeats that
are immunodominant in natural infections. One of
these is JL8, a cytoplasmic repetitive antigen, homol-
ogous to antigens CRA, Ag30 and TCR27, com-
posed of arrays of tandemly repeated 14 amino
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acid sequences [3^6]. JL8 recombinant proteins, pu-
ri¢ed from E. coli, as fusions to either glutathione S-
transferase (GST) or L-galactosidase, have been
tested as alternatives to the routine serological tests
based on the fact that anti-JL8 antibodies were
found in a great majority of chronically infected in-
dividuals [7,8].
Synthetic peptides derived from the repeat sequen-
ces of JL8 have been tested as substitutes for the
complex antigen in ELISA. This approach, although
showing high speci¢city, has proven less sensitive
than the classical methods for detection of antibodies
against T. cruzi, requiring the use of combinations of
di¡erent peptides of large sizes for obtaining a sen-
sitivity comparable to the complex mixture of anti-
gens [9,10]. There is an increasing need for the devel-
opment of diagnostic tools that are as sensitive as the
complex antigen for the detection of antibodies in
sera of patients. Ideally, this would comprise a mix-
ture of de¢ned molecules. Alternatively, recombinant
proteins expressing several epitopes from di¡erent T.
cruzi antigens could be employed to improve the
sensitivity of the immunological assays. This im-
provement requires the determination of immunodo-
minant epitopes in known major antigens. Thus a
detailed mapping of epitopes present in JL8 is rele-
vant to this approach.
LamB is a 421 amino acid, trimeric, integral outer
membrane protein of Escherichia coli, involved in the
permeation of maltose and maltotriose, and is re-
quired for the transport of higher dextrins [11]. Het-
erologous sequences can be inserted within ‘permis-
sive sites’ of the LamB protein known to be exposed
at the surface of the cell and at the surface of the
protein [12,13]. LamB can be expressed in high
amounts by E. coli and can be easily puri¢ed.
Here we describe the use of the LamB protein as a
carrier of JL8 sequences in order to map immunodo-
minant B cell epitopes in this protein, as an alterna-
tive for synthetic peptide-based mapping.
2. Materials and methods
2.1. Bacterial strain and plasmid
The E. coli strain POP6510 (thr leu tonB thi lacYi
recA dex-5 metA supE) and plasmid pAJC264, which
carries the lamB gene under the control of the tac
promoter [12], were a kind gift of Dr. M. Hofnung
(Institute Pasteur, Paris, France). The lamB gene in
pAJC264 contains a BamHI site for insertions be-
tween amino acids 153 and 154. Luria broth and
Luria agar supplemented with ampicillin (100 Wg/
ml) were used for the growth of bacteria. The ex-
pression of LamB was induced by the addition of
isopropyl-D-thiogalactoside (IPTG) (1033 M) to the
cultures at 0.7 A600 followed by an incubation of 4 h.
2.2. Synthetic oligonucleotides and DNA
constructions
Complementary oligonucleotide pairs correspond-
ing to ¢ve di¡erent sequences of JL8 (GeneBank
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Table 1
Oligonucleotides corresponding to the JL8 sequences
5P GATCCAGTTGCCGAAGCGGAGAAGCAGAAGGCAGCTGAAGCCACGAAGAAT 3P JL8.1
5P GATCATTCTTCGTGGCTTCAGCTGCCTTCTGCTTCTCCGCTTCGGCAACTG 3P
5P GATCCAGCGGAGAAGCAGAAGGCAGCTGAAGCCACGAAGGTTGCCGAAAAT 3P JL8.2
5P GATCATTTTCGGCAACCTTCGTGGCTTCAGCTGCCTTCTGCTTCTCCGCTG 3P
5P GATCCACAGAAGGCAGCTGAAGCCACGAAGGTTGCCGAAGCGGAGAAGAAT 3P JL8.3
5P GATCATTCTTCTCCGCTTCGGCAACCTTCGTGGCTTCAGCTGCCTTCTGTG 3P
5P GATCCAGCTGAAGCCACGAAGGTTGCCGAAGCGGAGAAGCAGAAGGCAAAT 3P JL8.4
5P GATCATTTGCCTTCTGCTTCTCCGCTTCGGCAACCTTCGTGGCTTCAGCTG 3P
5P GATCCAACGAAGGTTGCCGAAGCGGAGAAGCAGAAGGCAGCTGAAGCCAAT 3P JL8.5
5P GATCATTGGCTTCAGCTGCCTTCTGCTTCTCCGCTTCGGCAACCTTCGTTG 3P
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accession number J04016), representing permutations
that would encompass one repetition unit (Table 1),
were inserted in the BamHI site of pAJC264. The 5P
end of the coding oligonucleotides contained a Bam-
HI half site to provide a rapid restriction analysis
screen for the plasmids carrying the insertions. Am-
picillin resistant transformants of strain POP6510
had their plasmids analysed for the presence of the
insert by digestion with the enzymes BamHI and
NcoI. The insertions were sequenced using a 20-
mer primer complementary to nucleotides located
69 bp upstream from the BamHI insertion site in
the lamB gene. A GST recombinant protein carrying
multiple repeats of JL8 was also produced. The bac-
terial expression system (GST fusion system, Phar-
macia) [14] was used to subclone and express a 351-
bp fragment [5] encoding 6.7 repeats of 14 amino
acids of JL8. The recombinant protein was puri¢ed
from IPTG-induced E. coli lysates by a⁄nity chro-
matography [14].
2.3. Puri¢cation of the LamB proteins
Bacterial cultures were grown in 50 ml of LB-am-
picillin, harvested, washed in 50 mM Tris-HCl, pH
8.0 and resuspended in 0.5 ml of 20% sucrose-100
mM Tris-HCl, pH 8.0. After the addition of 0.1 ml
EDTA 0.5 M and 0.2 ml lysozyme 10 mg/ml, the cell
suspensions were incubated at 37‡C for 15 min. 0.5
ml of extraction bu¡er (2% Triton X-100, 10 mM
MgCl2, 50 mM Tris-HCl, pH 8.0) was added, fol-
lowed by incubation at 30‡C for 30 min. The cell
membrane fraction was sedimented by centrifugation
at 2500Ug for 10 min and resuspended in 0.3 ml of
Laemmli sample bu¡er [15]. Samples were boiled for
5 min and the proteins were separated on preparative
10% SDS-PAGE. The LamB protein was visualized
by staining a strip of the gel with Coomassie blue.
The corresponding portion of the unstained gel was
isolated and LamB was eluted by incubation of the
gel slice in 10 ml ddH2O at 4‡C for 18 h. The eluted
protein was concentrated on Speed Vac0 and its
concentration was estimated by SDS-PAGE using
bovine serum albumin as standard.
2.4. Sera
Human chagasic sera were obtained from patients
with chronic Chagas’ disease diagnosed by serologi-
cal and clinical symptoms. Serological analyses were
performed by indirect immuno£uorescence, indirect
hemagglutination and complement ¢xation tests. All
the serum samples used in this work were positive in
ELISA tests with GST-JL8. For the ELISA assays
against the recombinant LamB fusion proteins the
sera were absorbed with puri¢ed wild-type LamB
protein (1 Wg of protein per Wl of serum). Serum
against the GST-JL8 fusion protein was raised on
New Zealand female rabbits immunized with the re-
combinant protein puri¢ed as described. The protein
(50 Wg) was injected subcutaneously with complete
Freund’s adjuvant. After 15 and 30 days from the
¢rst injection, 50 Wg of protein were injected in in-
complete Freund’s adjuvant. The rabbits were bled
30 days after the third injection.
3. Results and discussion
3.1. Expression of the JL8 sequences as fusions with
LamB protein
Five di¡erent 14 amino acid sequences, derived
from JL8, representing permutations that would en-
compass one repetition unit, were inserted between
residues 153 and 154 of LamB, in an unstructured
loop known to be exposed on the surface of the
protein, facing the cell exterior (Fig. 1) [13]. The
expression of the recombinant LamB proteins was
determined by immunoblots of whole cell extracts
of bacteria induced for the expression of the fusion
proteins (Fig. 2A). All ¢ve JL8-LamB proteins were
recognized by antiserum raised against a GST-JL8
recombinant fusion protein, as indicated by the pres-
ence of bands with the expected molecular mass of
about 48 kDa. The recombinant LamB proteins were
expressed at the same levels as the wild-type LamB
FEMSLE 8209 29-6-98
Fig. 1. Amino acid sequences derived from the JL8 repeats in-
serted in the LamB protein.
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and fractionated as outer membrane components.
The JL8-LamB fusions to be used in ELISA assays
were further puri¢ed from this preparation by elu-
tion from the gel (Fig. 2B). The yield of this proce-
dure was about 5 mg of puri¢ed protein per liter of
culture.
3.2. Mapping of antigenic regions of JL8
The ¢ve JL8-LamB fusion proteins were tested by
ELISA with 12 serum samples from chronic chagasic
patients (Table 2). We have selected sera with di¡er-
ent reactivity values against the GST-JL8 fusion pro-
tein. All the sera reacted with JL8.2 and the reactiv-
ity values obtained with this construction were
signi¢cantly higher than those obtained with any of
the other LamB fusion proteins. These data strongly
suggest that the sequence AEKQKAAEATKVAE,
present in JL8.2, contains the immunodominant epit-
ope of JL8.
The presence of other antigenic determinants
along the JL8 protein was assessed by testing all
¢ve JL8-LamB fusion proteins against 80 serum sam-
ples from human chronic chagasic patients, which
had been previously shown to react with the GST-
JL8 fusion protein. A panel of 52 normal human
sera was used as a negative control. About 74% of
the chagasic sera reacted with any one of the ¢ve
JL8-LamB fusion proteins, assuming a cut o¡ ab-
sorbance value equal to three times the average ab-
sorbance value of the normal sera. The JL8.2-LamB
fusion was recognized by 64% of the chagasic sera
FEMSLE 8209 29-6-98
Table 2
Recognition of LamB fusion proteins by chagasic sera
Sera Fusion proteins
JL8.1 JL8.2 JL8.3 JL8.4 JL8.5
Normal.1 0.009 0 0 0 0.025
Normal.2 0.052 0 0 0 0.079
P.1 0 0.558 0 0 0
P.2 0 0.980 0 0 0
P.5 0 0.210 0 0 0
P.7 0.008 0.058 0 0 0
P.8 0.067 0.326 0 0 0
P.9 0.038 0.175 0 0 0
P.10 0 0.484 0 0.039 0
P.11 0.130 0.614 0 0 0
CHB 0 1.061 0 0 0
DPG 0.050 0.139 0.016 0 0.014
DPJ 0.297 0.480 0 0 0
DPL 0.019 0.102 0.016 0.013 0
DPM 0.062 0.693 0.185 0 0
Microplates (Nunc) were coated with the puri¢ed wild-type or
recombinant LamB proteins (50 ng/well) diluted in carbonate bu¡-
er (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6). The wells were
washed three times with PBS-Tween 0.05% and blocked with 5%
low-fat milk for 2 h at 37‡C. Chagasic sera (1:200) that were
previously absorbed with the wild-type LamB proteins overnight
at 4‡C were added and the plates were incubated for 1 h at 37‡C.
After three washes with PBS-Tween 0.05%, rabbit anti-human IgG
peroxidase conjugate diluted 1:2000 (DAKO) was added and the
plates were incubated for 1 h at 37‡C, before development with o-
phenylenediamine dihydrochloride. Numbers correspond to the
average A492 value of triplicate ELISA’s, discounted of the A492
value obtained with the puri¢ed wild-type LamB protein.
Fig. 2. Expression and puri¢cation of the JL8-LamB fusion pro-
teins. A: Immunoblot of whole cell extracts of E. coli expressing
the JL8-LamB fusion proteins reacted with an antiserum raised
against GST-JL8. The strains POP6510 and POP6510 carrying
the lamB gene without insert (LamB) were used as negative con-
trols. E. coli cells were lysed by boiling for 5 min in Laemmli
sample bu¡er [15]. Proteins were transferred to nitrocellulose
membranes (Hybond-C Extra, Amersham) at 1A for 2 h using
the bu¡er conditions described [16]. The membranes were
blocked with 5% low-fat milk in phosphate-bu¡ered saline (PBS)
for 1 h at room temperature, and incubated for 1 h with rabbit
serum raised against puri¢ed GST-JL8 recombinant fusion pro-
tein, diluted 1:100. After three washings with 0.05% Tween 20 in
PBS, bound antibodies were reacted with goat anti-rabbit IgG
conjugated with peroxidase (Sigma), diluted 1:1000. After incu-
bation for 1 h with the conjugate and washing in PBS, the
bound antibodies were detected using the 4-chloro naphtol
chromogen. B: Coomassie blue staining of 10% SDS-PAGE of
wild-type LamB and JL8.2-LamB fusion proteins after elution
from preparative gels. Molecular mass standards are indicated on
the left, in kDa.
C.M. Pereira et al. / FEMS Microbiology Letters 164 (1998) 125^131128







(51 out of 80 sera tested). Twenty-one of these were
also capable of recognizing JL8.1 and/or JL8.3,
although with lower reactivities. Only eight sera dis-
played reactions against epitopes other than JL8.2.
These data strongly support the suggestion that the
sequence AEKQKAAEATKVAE, present in JL8.2,
contains the immunodominant JL8 epitope. Twenty-
one sera (26%) did not react with any of the fusion
proteins, indicating the existence of other conforma-
tional and/or discontinuous antibody binding site(s)
in the JL8 antigen, which is not present in the LamB
constructs. Discontinuous and/or conformational de-
pendent epitopes formed by two or more repeats
may have been excluded from this analysis, due to
the constraint in size imposed by our mapping strat-
egy.
3.3. The anti-JL8.2 reactivity of the chagasic sera is
speci¢cally directed against the JL8 antigen
In order to determine whether the antibodies that
recognize JL8 in chagasic chronic patients sera were
directed mainly to the epitope in JL8.2, this LamB
fusion was tested for its ability to inhibit the binding
of human chagasic sera to GST-JL8 in a competitive
ELISA. Fig. 3 shows the results obtained with
3 chagasic sera, that showed high levels of anti-JL8
reactivity. JL8.2-LamB was capable of inhibiting the
recognition of the JL8 antigen by the human chaga-
sic sera, in a concentration dependent manner, giving
further support for the suggestion that the sequence
AEKQKAAEATKVAE contains the immunodomi-
nant JL8 epitope.
FEMSLE 8209 29-6-98
Fig. 3. Inhibition ELISA. Human chagasic sera (P.1, P.2 and CHB) diluted to 1:400 were pre-incubated with the JL8.2-LamB protein, in
the indicated concentrations (ng), and added to microtiter plate wells previously coated with GST-JL8 recombinant fusion protein (50 ng/
well), diluted in carbonate, at 4‡C overnight, washed three times with PBS-Tween 0.05% and blocked with 5% milk for 2 h at 37‡C. The
wild-type LamB protein was used as a negative control. The average A492nm values from duplicate experiments are indicated on the verti-
cal axis.
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The constructions used in this work start at di¡er-
ent points of the 14 amino acid consensus repeat of
JL8 antigen, with their sequences shifted by 3 amino
acids relative to each other. JL8.2 di¡ers from the
other constructions by the presence of three pairs of
alanine and glutamic acid residues (AE pair), sepa-
rated by a stretch of 4 amino acids. In JL8.1, JL8.3,
JL8.4 and JL8.5, the AE pair is repeated three times,
but two of them are contiguous. The strong reactiv-
ity of JL8.2 with chagasic sera could be explained by
the existence of a discontinuous epitope made up of
three non-contiguous AE pairs which could be
brought together by folding of the polypeptide chain.
This discontinuous epitope is contained within a se-
quence that has been identi¢ed as a linear epitope
using the algorithm developed by Pellequer et al.
[17]. In fact, this may be a general trend of epitopes
from proteins that are antigenic in the T. cruzi in-
fection. Recently, ¢ne epitope mapping of the C-ter-
minal epitope of the T. cruzi ribosomal P protein
revealed that the epitope was not linear but discon-
tinuous and de¢ned by two acidic residues separated
by 9 amino acids [18]. The low reactivities of other
JL8 constructions with the chagasic sera could be
due to a continuous linear epitope (VAEAEK)
present in these constructions.
The presence of an immunodominant discontinu-
ous epitope in JL8 antigen is reinforced by the re-
sults obtained with a synthetic peptide composed of
two 14 amino acid repeats of JL8, which reacted
with 58% of the human chronic chagasic sera tested
[10]. On the other hand, JL8 recombinant proteins
that carry many 14 amino acid repeats, such as GST-
JL8 and L-galactosidase-JL8 fusions, are recognized
by a large proportion of human chagasic sera (from
85 to 100%) [7,8]. This is a clear indication that
synthetic peptides are not able to mimic the immu-
nodominant epitopes present in JL8 recombinant
proteins.
Our results show that fusions to LamB may pro-
vide a simple and useful method to de¢ne and map B
cell epitopes, overcoming obstacles inherent to syn-
thetic peptides, such as insolubility and conforma-
tional variations. In this regard, the fact that the
site for insertions in LamB is part of a non-struc-
tured loop provides the possibility for the heterolo-
gous sequence to take on a conformation that
mimics the native protein. Although LamB proteins
can be easily puri¢ed from the outer membrane of E.
coli in large amounts, the presence in human sera of
antibodies directed to LamB domains can impose
some restrictions in their use for diagnostic purposes.
Previous absorption of sera with wild-type LamB
can overcome this problem as shown here. These
natural antibodies are mainly directed towards a re-
cently identi¢ed immunodominant sequence of
LamB, and the deletion of this region drastically
reduces reaction with human sera (Pereira, C.M.,
Newton, S. and Castilho, B.A., unpublished results).
Therefore, the LamB fusion proteins devoid of this
sequence could be used in diagnostic tests for Chagas
disease. Moreover, it should be mentioned that the
epitopes described here were detected by immuno-
£uorescence on the surface of the bacteria (data
not shown); thus, the intact cells adsorbed directly
to the microtiter plates could potentially be used in
diagnostic tests. However, since some human sera
may be highly reactive to E. coli, they should be
previously absorbed with an extract of E. coli that
does not express JL8.
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